[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fKLxW28uOi40g7X6YRlOEC8Ec8ED6J7MXqKBt0BMFx60":8,"$fa_E8E7FHczpC2ex0Yk5lPjCXQIBNGhdjgeuGK2-sI2M":60,"$fWH1SNzHLREwhPGwbLUM-UtpLAG_-3VtduQ2hTter9YY":61,"$fY5qSDhcVbdWX-bcPXeJZAalVVJXN0Blp9TDCLWGk4wY":65},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":59},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"roleType":17,"adept":18,"hospital":19,"department":20,"postsTitle":21,"materialTotal":22,"videoTotal":23,"isConcern":7,"title":24,"coverVertical":25,"coverAcross":26,"directionMarker":27,"description":28,"vid":29,"time":30,"mediaType":27,"views":31,"likes":17,"isThumbsUp":7,"isCollection":7,"collections":17,"createTime":32,"seoTitle":33,"seoKeywords":34,"seoDescription":35,"shelvesTime":36,"menus":37,"menuId":39,"type":22,"quality":56,"commentCount":17,"isComment":27,"deviceType":57,"url":58},11395,864270,[],"https://ystcdn.venuertc.com/medical/ystApp/XRd4QdmnhhDirVWofQ8ystNdDgbIHCyL.png","王美华",0,"高血压糖尿病心血管疾病的诊疗，慢性疾病管理、皮肤病和过敏反应、消化系统疾病、急性疾病和急救处理等,","长桥街道社区卫生服务中心","全科医疗","主治医师",2,6,"肺纤维化的认识与药物进展","","https://cdn.yishi-tong.com/console/3/LOw1Si0C8CAaN2eozAlHfCx_j9SsoJOZ.png",1,"WEBVTT\n\n00:02.130 --> 00:02.880\n大家好。\n\n00:03.821 --> 00:04.221\n今天呢，\n\n00:04.221 --> 00:10.170\n我来和大家一起学习一下关于肺纤维化的认识与药物进展，\n\n00:10.321 --> 00:11.770\n这么一个主题。\n\n00:15.713 --> 00:19.239\n首先我们来看一下关于肺纤维化的一个认识。\n\n00:19.388 --> 00:20.038\n认识。\n\n00:22.589 --> 00:23.989\n什么是非新文化？\n\n00:24.704 --> 00:27.554\n肺纤维化是一种严重的肺部疾病，\n\n00:27.903 --> 00:32.554\n其持续进展将导致肺换气功能障碍，\n\n00:32.804 --> 00:34.554\n进而出现呼吸衰竭，\n\n00:34.554 --> 00:37.054\n严重影响患者的生心健康。\n\n00:37.796 --> 00:42.596\n临床上的肺纤维化一般是指间质性肺疾病一个终末期改变。\n\n00:45.159 --> 00:45.633\n纤维化呢，\n\n00:45.633 --> 00:47.183\n我们看一下纤维化，\n\n00:47.183 --> 00:49.784\n我们知道是一个正常人体组织受损后，\n\n00:49.784 --> 00:53.609\n被过度真正的纤维组织替代的这么一个过程。\n\n00:54.819 --> 00:55.844\n那么关于肺行为的话，\n\n00:55.844 --> 01:00.469\n我们就是肺部受损组织自我觉物只有留下疤痕这么一个过程。\n\n01:01.737 --> 01:02.162\n我们知道，\n\n01:02.162 --> 01:02.812\n肺组织呢，\n\n01:02.812 --> 01:05.138\n一个分为肺实质和肺间质。\n\n01:05.138 --> 01:05.962\n肺实质呢，\n\n01:05.962 --> 01:08.138\n主要是包括一个支气管肺泡。\n\n01:08.587 --> 01:09.538\n肺间质呢，\n\n01:09.538 --> 01:13.388\n主要包括结缔组织、淋巴管、神经纤维及血管。\n\n01:14.474 --> 01:15.349\n肺间质呢，\n\n01:15.349 --> 01:17.125\n分布在各个肺实质之间，\n\n01:17.125 --> 01:21.175\n起到一个连接充体、固定营养等作用。\n\n01:21.796 --> 01:23.347\n保证了肺组织的弹性，\n\n01:23.546 --> 01:26.147\n让肺泡可以储存大量的氧气。\n\n01:26.497 --> 01:29.796\n保证人类体肺组。\n\n01:34.313 --> 01:34.712\nNext.\n\n01:35.836 --> 01:37.736\n对间质性疾病的一个分类。\n\n01:42.109 --> 01:44.808\n主要是一个间质性肺疾病，\n\n01:44.958 --> 01:46.783\n我们简称为ILD，\n\n01:46.783 --> 01:50.658\n还有一个弥漫性实质性肺疾病EPLD。\n\n01:53.079 --> 01:53.278\n嗯。\n\n01:55.098 --> 01:55.399\n一个呢，\n\n01:55.399 --> 01:57.448\n就是那个特发性的间质性肺炎，\n\n01:57.549 --> 01:58.524\n就是RRP，\n\n01:58.524 --> 02:01.348\n包括特发性肺性化、特发性肺。\n\n02:02.152 --> 02:05.027\n肺间质性非特异性间质性肺炎，\n\n02:05.027 --> 02:07.902\n还有特发性胸膜肺团体纤维增生症。\n\n02:08.789 --> 02:15.139\n过性性间质性肺炎、淋巴细胞性间质性肺炎、呼细胞支一管发间质性肺病。\n\n02:16.457 --> 02:17.307\n演员性。\n\n02:18.522 --> 02:18.723\n嗯。\n\n02:22.304 --> 02:24.054\n还有急性间质性肺炎。\n\n02:25.231 --> 02:26.656\n还会分类的开发。\n\n02:26.656 --> 02:27.231\n你进行。\n\n02:29.975 --> 02:30.500\n第二部分呢，\n\n02:30.500 --> 02:31.225\n就是一个方。\n\n02:32.175 --> 02:34.524\n就是一个结缔组织病的相关。\n\n02:36.242 --> 02:43.542\nEPD包括系统性硬化症、类风性关节炎、炎症性疾病、原发性专家综合症、混合性结缔组织病。\n\n02:44.602 --> 02:51.177\nANCA相关血管与协同性红斑蓝斑具有免疫学特征的竞争对。\n\n02:52.787 --> 02:53.037\n还有呢，\n\n02:53.037 --> 02:56.337\n就是环境和暴露相关的EPOD，\n\n02:56.638 --> 03:01.988\n包括过敏性病、尘肺、药物和毒品相关的IOD，\n\n03:02.037 --> 03:03.738\n时刻相关的IOD。\n\n03:06.039 --> 03:06.389\n然后呢，\n\n03:06.389 --> 03:09.039\n就是这个肉压总性疾病相关的一个。\n\n03:09.936 --> 03:18.535\nEPIOD包括结节病、抗组织细胞增高症、嗜酸性粒细胞病、其他热芽种性疾病。\n\n03:19.817 --> 03:20.567\n还了一些，\n\n03:20.867 --> 03:21.466\n最后呢，\n\n03:21.466 --> 03:24.516\n是一些遗传或者其他原因的BTILG，\n\n03:24.567 --> 03:26.117\n包括家族性IL，\n\n03:26.667 --> 03:30.367\n家族性肺泡蛋白神经性疾病原因。\n\n03:34.869 --> 03:36.669\n肺纤维化的症状看一下，\n\n03:36.718 --> 03:39.343\n大部分肺纤维化患者可见杵状子，\n\n03:39.343 --> 03:43.018\n表现为手指或足趾远端的增生肥厚，\n\n03:43.018 --> 03:44.069\n呈杵状，\n\n03:44.718 --> 03:46.218\n就这样子一生呢。\n\n03:47.115 --> 03:47.341\n患者，\n\n03:47.341 --> 03:48.766\n两边肌部能起。\n\n03:49.757 --> 03:51.057\n题末细选的。\n\n03:52.322 --> 03:56.222\n本自己的暴力。\n\n04:00.429 --> 04:02.904\n它的疾病早期的飞行癌，\n\n04:02.904 --> 04:04.154\n疾病早期的症状呢，\n\n04:04.154 --> 04:05.580\n是比较隐匿的，\n\n04:05.580 --> 04:06.880\n很难被人发现。\n\n04:08.841 --> 04:10.667\n有些人可能活动过后出现，\n\n04:10.667 --> 04:13.117\n可能出现一些呼吸困难，\n\n04:13.117 --> 04:14.242\n疾病进展期呢，\n\n04:14.242 --> 04:17.041\n就是说症状促进。\n\n04:17.919 --> 04:19.419\n明显神经炎加重，\n\n04:19.468 --> 04:23.569\n严重的在间间隙的情况下也会出现呼吸困难。\n\n04:23.819 --> 04:25.718\n还有一个是持续性的干咳，\n\n04:25.819 --> 04:28.868\n少数患者会有咯血、胸动和米。\n\n04:29.069 --> 04:30.419\n到今天晚期的话呢，\n\n04:30.419 --> 04:31.569\n有明显的沉长，\n\n04:32.019 --> 04:34.368\n肺动脉高压和尿性功能不全，\n\n04:35.019 --> 04:36.618\n用呼吸衰竭症至少。\n\n04:40.118 --> 04:42.067\n那肺纤维化的一些检查，\n\n04:42.768 --> 04:45.417\n你症方面主要是一个呼吸频率一个增快，\n\n04:45.917 --> 04:48.567\n就是IOD的一个最早的表现，\n\n04:48.567 --> 04:49.118\n还有呢，\n\n04:49.118 --> 04:50.217\n就是双下肺。\n\n04:51.070 --> 04:52.619\n这个音发音或者。\n\n04:54.036 --> 04:55.885\n没有这种单子。\n\n04:58.653 --> 04:59.053\nGood.\n\n05:01.204 --> 05:03.403\n比较常规的还有一个胸部X线检查。\n\n05:04.398 --> 05:04.648\n嗯，\n\n05:04.648 --> 05:07.648\n主要的表现的有一个是弥漫性的阴影。\n\n05:08.576 --> 05:09.027\n或者是。\n\n05:10.268 --> 05:11.192\n接地性的。\n\n05:12.093 --> 05:12.894\n因自性命令，\n\n05:12.894 --> 05:13.294\n这个呢，\n\n05:13.294 --> 05:13.993\n比较少见。\n\n05:15.311 --> 05:15.710\n在。\n\n05:18.160 --> 05:18.510\n然后呢，\n\n05:18.510 --> 05:19.385\n再下一步呢，\n\n05:19.385 --> 05:21.160\n可以有一个非CT的检。\n\n05:23.078 --> 05:24.928\n有利于发现早期病变，\n\n05:25.178 --> 05:28.953\n如肺内呈现不规则的心条网格样改变，\n\n05:28.953 --> 05:30.928\n伴有个男性小细常形成。\n\n05:32.394 --> 05:33.894\n还有一个那个肺功能的检测。\n\n05:34.993 --> 05:37.044\n包括限制性通气功能障碍。\n\n05:37.907 --> 05:41.958\n弥漫型降低伴低压血症或一性呼吸衰竭等等。\n\n05:42.308 --> 05:43.407\n有这类表现。\n\n05:46.960 --> 05:49.561\n还有很多医院的一个支气管肺泡的一个灌洗。\n\n05:50.730 --> 05:51.131\n临近。\n\n05:52.583 --> 05:55.833\nBALF中炎症免疫效应细胞的比例，\n\n05:55.833 --> 06:00.483\n可将IOD分别为淋巴细胞增多型和中性粒细胞增多。\n\n06:04.552 --> 06:07.002\n这个病理学方面有一个组织病理学检查。\n\n06:07.886 --> 06:14.011\n对于HRCG神经不典型的URP改变的诊断不清楚，\n\n06:14.011 --> 06:15.861\n以及没有手术禁忌症的患者，\n\n06:15.861 --> 06:18.986\n可以考虑那个外科的肺活体。\n\n06:20.174 --> 06:20.350\n嗯，\n\n06:20.350 --> 06:21.274\n明确什么的。\n\n06:23.951 --> 06:26.101\n下面我们来看一下最新文化的规。\n\n06:26.752 --> 06:27.802\n主要是一个。\n\n06:28.639 --> 06:30.289\n就是微信的话呢，\n\n06:30.289 --> 06:30.789\n就是。\n\n06:31.656 --> 06:32.406\n难以治愈，\n\n06:33.105 --> 06:35.555\n它的一个很多非精神疾病，\n\n06:35.555 --> 06:37.605\n很多非一个一个晚疾病的，\n\n06:37.605 --> 06:38.455\n所以难以治愈，\n\n06:38.455 --> 06:42.605\n只能通过治疗控制肺纤维化的一个疾病发展。\n\n06:44.569 --> 06:44.843\n然后呢，\n\n06:44.843 --> 06:46.794\n会造成患者的肺部缺氧，\n\n06:46.794 --> 06:47.868\n造成呼吸困难，\n\n06:48.169 --> 06:49.118\n应该就是这个。\n\n06:51.394 --> 06:53.343\n还会引起一个肺大泡和气胸。\n\n06:55.475 --> 06:55.774\n对呢，\n\n06:55.774 --> 06:56.774\n他。\n\n06:57.916 --> 06:58.217\n这个。\n\n06:59.299 --> 07:01.248\n并随着肺部疾病的减少呢，\n\n07:01.248 --> 07:01.873\n最终呢，\n\n07:01.873 --> 07:03.398\n可以引起一个肺心病。\n\n07:04.535 --> 07:05.635\n一旦肺行病出现的，\n\n07:05.635 --> 07:10.285\n可能因为心脏衰竭引起患者丧失劳动力甚至死亡。\n\n07:13.502 --> 07:13.902\n你。\n\n07:15.597 --> 07:17.997\n飞行的话会加速患者的一个死亡。\n\n07:21.001 --> 07:21.300\n是。\n\n07:24.463 --> 07:31.812\n诊断ID到近在的时间是一般都是一年多以后一个处理期。\n\n07:33.394 --> 07:33.493\n来，\n\n07:33.493 --> 07:34.743\n我们看一下第二部分。\n\n07:36.236 --> 07:40.187\n关于肺纤维化的一个机制以及药物的一个进程。\n\n07:41.450 --> 07:43.200\n肺心膜这个发病机制。\n\n07:44.096 --> 07:44.496\n老齐。\n\n07:45.588 --> 07:48.988\n第一个就是早期新文化启动阶段，\n\n07:49.287 --> 07:49.687\n嗯，\n\n07:50.088 --> 07:51.162\n一病特异性，\n\n07:51.162 --> 07:55.187\n然后主要这个病理改变就是一个环境老化，\n\n07:55.238 --> 07:56.388\n遗传遗传。\n\n07:57.303 --> 08:01.003\n肺泡上皮和血管内的内壁的损伤啊，\n\n08:01.003 --> 08:04.053\n到这个测氧刺激免疫反应热亚中心。\n\n08:05.511 --> 08:06.011\n然后呢，\n\n08:06.161 --> 08:10.761\n后面就引一个新文化的一个进一个过程。\n\n08:15.104 --> 08:16.104\n到晚期呢，\n\n08:16.104 --> 08:17.354\n就是纤维化，\n\n08:17.354 --> 08:18.753\n纤维化机制共享。\n\n08:20.989 --> 08:25.139\n包括TGF贝塔、CTGFGF。\n\n08:26.552 --> 08:29.601\nWAP这个这能机制中型，\n\n08:29.851 --> 08:32.802\n这个导致一个持续的金融化现制。\n\n08:33.773 --> 08:36.473\n治疗方面的一个就是一个从新文化的资源。\n\n08:39.094 --> 08:39.469\n目前呢，\n\n08:39.469 --> 08:44.195\n已经三次按纤维化治疗药物这两种包，\n\n08:44.594 --> 08:45.244\n这是。\n\n08:47.323 --> 08:48.023\n你非你懂，\n\n08:48.023 --> 08:49.648\n还有一个是你不，\n\n08:49.648 --> 08:50.624\n你打尼布。\n\n08:54.159 --> 08:55.059\n新药临床一点，\n\n08:55.059 --> 08:57.284\n在新药临床研究阶段呢，\n\n08:57.284 --> 08:59.984\n就是现在的就在3期呢，\n\n08:59.984 --> 09:00.659\n有3个，\n\n09:00.659 --> 09:02.684\n在二期床C阶段有22个，\n\n09:02.684 --> 09:03.284\n一期呢，\n\n09:03.284 --> 09:04.159\n有27个，\n\n09:04.409 --> 09:05.484\n药物类型呢，\n\n09:05.484 --> 09:08.309\n主化药化学药物方面35个，\n\n09:08.309 --> 09:10.059\n在生物药方面是4个，\n\n09:10.059 --> 09:11.184\n研发国家呢，\n\n09:11.184 --> 09:12.510\n国外33。\n\n09:13.296 --> 09:14.197\n中国16层。\n\n09:17.841 --> 09:18.192\n你是。\n\n09:18.950 --> 09:20.950\n我觉得三四的是比较少的一个，\n\n09:21.950 --> 09:26.351\n它在临床临床期或者研究阶段的品种还是有。\n\n09:27.513 --> 09:28.263\n比非尼种呢，\n\n09:28.263 --> 09:30.338\n主要通过比非尼种呢，\n\n09:30.338 --> 09:35.314\n就是我们前面讲主要通过中医TGF贝塔DF阿尔法，\n\n09:35.314 --> 09:35.814\n华为。\n\n09:38.020 --> 09:38.221\n嗯。\n\n09:39.658 --> 09:40.809\n临床试验的表明，\n\n09:41.008 --> 09:50.109\n比非尼种治疗除IPF以外的PFILD可情往患者无疑是下降趋势，\n\n09:50.359 --> 09:53.559\n是PFILD患者的合理选择。\n\n09:57.192 --> 10:01.367\n主要是一个通过抑制TGF贝塔一接到肺纤维化，\n\n10:01.367 --> 10:04.492\n抑制TMF阿尔法特性因子，\n\n10:04.492 --> 10:07.018\n减少成纤维细胞增殖，\n\n10:07.018 --> 10:08.768\n抑制成纤维细胞分化，\n\n10:08.768 --> 10:10.268\n减少胶原沉积。\n\n10:14.356 --> 10:14.606\n嗯，\n\n10:14.755 --> 10:15.755\n一旦你呢，\n\n10:15.755 --> 10:16.705\n通过作用于，\n\n10:16.856 --> 10:17.255\n嗯。\n\n10:18.656 --> 10:19.031\nEdg.\n\n10:19.031 --> 10:22.581\nFR和VEGF2和F，\n\n10:22.581 --> 10:22.831\nG,\n\n10:22.831 --> 10:24.706\nFR发挥非纤维化。\n\n10:27.091 --> 10:27.841\n研究，\n\n10:27.892 --> 10:30.492\n它是一种酪氨酸激酶抑制剂，\n\n10:30.742 --> 10:34.242\n研究显示的你达内部有效痉挛。\n\n10:35.187 --> 10:38.262\nCTDLD患者的FVC下反率。\n\n10:40.601 --> 10:41.351\n它的抗纤化，\n\n10:41.401 --> 10:42.651\n抗纤维化机制呢，\n\n10:42.651 --> 10:47.051\n主要是一个是抑制血小板引发生长因子受体。\n\n10:48.455 --> 10:52.005\n还有个是抑制血管内壁生长因子受体，\n\n10:52.056 --> 10:53.531\n还有个抑制成细胞，\n\n10:53.531 --> 10:55.005\n细胞生长因子受体。\n\n10:59.250 --> 10:59.700\n还给吗？\n\n11:02.010 --> 11:03.460\n在临床试验中的分析，\n\n11:03.460 --> 11:09.859\n有这个免性疾病相关的RLD患者在52周年的LP下降率。\n\n11:15.682 --> 11:15.932\n好了，\n\n11:15.932 --> 11:19.482\n就是下降相对相对安慰剂组可以。\n\n11:21.973 --> 11:23.523\n多下降58%。\n\n11:29.841 --> 11:30.041\n嗯。\n\n11:31.450 --> 11:33.776\n我们看一下这两个药物的不良反应，\n\n11:33.776 --> 11:34.151\n嗯，\n\n11:34.450 --> 11:38.825\n尼肺比比肺尼肿的不良反应主要是一个是胃肠道反应，\n\n11:38.825 --> 11:41.776\n包括恶心、消化不良、呕吐、呕吐。\n\n11:41.776 --> 11:43.776\n因食皮肤疾病呢，\n\n11:43.776 --> 11:45.500\n是光过敏出现皮疹。\n\n11:47.013 --> 11:49.164\n还有一个是可能出现肝功能损害。\n\n11:50.353 --> 11:51.052\n我过这个。\n\n11:52.661 --> 11:56.536\n天门冬氨酸氨基酸基转移酶，\n\n11:56.536 --> 11:58.911\n还有那个丙氨酸氨基转移酶。\n\n12:00.421 --> 12:01.421\n以及肾高，\n\n12:01.721 --> 12:03.620\n甚至有可能发生肝功衰竭，\n\n12:03.620 --> 12:05.046\n要定期检查肝功能。\n\n12:05.046 --> 12:06.070\n神经系统方面，\n\n12:06.070 --> 12:08.570\n主要是一个是睡神面形志波动。\n\n12:09.594 --> 12:09.695\n嗯，\n\n12:09.695 --> 12:14.544\n一大内部的不良反应主要是一个腹泻和使内部大酶升高。\n\n12:15.348 --> 12:15.973\n食欲下降，\n\n12:15.973 --> 12:16.547\n疼痛。\n\n12:17.450 --> 12:18.601\n比生经济和高效。\n\n12:20.169 --> 12:22.669\n那些不良老年人肯定对吧？\n\n12:24.085 --> 12:27.885\n这个意思意思一个。\n\n12:30.947 --> 12:33.197\n还有一个就是一个血小板那个减少症。\n\n12:36.070 --> 12:36.869\n可能会发生。\n\n12:43.914 --> 12:48.263\n然后我们来看一下非行化的一个中医药治疗方面的研究，\n\n12:48.364 --> 12:48.763\n嗯。\n\n12:53.820 --> 12:54.494\n病因清楚，\n\n12:54.494 --> 12:56.770\n整体框用药安全有效，\n\n12:56.869 --> 13:00.619\n这是中医药治疗的一些一个优点。\n\n13:01.338 --> 13:01.862\n病因呢，\n\n13:01.862 --> 13:03.062\n就是肺心的话，\n\n13:03.062 --> 13:04.862\n多属于中医的肺为范畴。\n\n13:04.862 --> 13:05.937\n其病因在肺，\n\n13:05.937 --> 13:08.663\n久治其肾治疗总原则呢，\n\n13:08.663 --> 13:10.088\n是一个补肺生精。\n\n13:10.338 --> 13:11.487\n肺为急性剂，\n\n13:11.487 --> 13:13.763\n单一化痰清肺为主，\n\n13:13.763 --> 13:14.987\n缓解剂单一。\n\n13:15.854 --> 13:17.255\n固扶正固本为主，\n\n13:17.255 --> 13:18.255\n兼以驱邪。\n\n13:19.232 --> 13:19.482\n嗯。\n\n13:21.815 --> 13:22.190\n治疗的，\n\n13:22.190 --> 13:24.341\n中医治疗也是明确有效的，\n\n13:24.341 --> 13:27.466\n可以改善患者的呼吸困难的症状，\n\n13:27.466 --> 13:29.366\n延缓疾病的进展。\n\n13:30.090 --> 13:33.815\n完了跟前面两个需要相比较的，\n\n13:33.815 --> 13:35.640\n相对来说不良反应是较小，\n\n13:35.640 --> 13:37.039\n安全性是比较。\n\n13:43.697 --> 13:44.997\n冬虫夏草，\n\n13:45.047 --> 13:47.497\n中医药方面主要的一个冬虫夏草制剂，\n\n13:47.497 --> 13:48.297\n具有抗炎，\n\n13:48.297 --> 13:50.797\n抗氧化和抗肺纤维化的作用。\n\n13:54.254 --> 13:57.504\n现在可以通过抑制TGF贝塔一的表达，\n\n13:57.754 --> 14:00.578\n调整一型和二型细胞因子平衡，\n\n14:00.578 --> 14:02.604\n达到抗纤维化的一个作用。\n\n14:07.164 --> 14:08.215\n那我们今天。\n\n14:09.125 --> 14:12.051\n总结一下今天这个课题的主要内容。\n\n14:12.051 --> 14:12.476\n第一步，\n\n14:12.476 --> 14:13.375\n第一个就是说。\n\n14:14.687 --> 14:14.888\n嗯。\n\n14:15.838 --> 14:17.914\n肺纤维化是一种严重的肺部疾病，\n\n14:17.914 --> 14:21.013\n其持续进展将导致肺泡肌骨胀，\n\n14:21.013 --> 14:22.489\n进而出现呼吸衰竭。\n\n14:23.140 --> 14:25.591\n严重影响患者的一个身心健康。\n\n14:26.851 --> 14:31.676\n目前临床上虽仍然缺乏对肺行化的特异性治疗方法，\n\n14:31.676 --> 14:35.151\n第三治疗肺纤化药物仅有两种，\n\n14:35.851 --> 14:37.401\n一个是比酰尼酮，\n\n14:37.450 --> 14:39.401\n还有一个是尼达尼布。\n\n14:41.729 --> 14:41.929\n嗯。\n\n14:43.106 --> 14:43.331\n然后呢，\n\n14:43.331 --> 14:45.432\n就是这两个第呢，\n\n14:45.432 --> 14:46.856\n我们看几看好，\n\n14:46.856 --> 14:48.906\n就是还是有一个呢，\n\n14:48.906 --> 14:52.257\n就是也不并非一个特异性的这两个，\n\n14:52.257 --> 14:55.706\n另外一个就是服装的女生对他是有。\n\n14:56.469 --> 14:57.469\n比较个副作用，\n\n14:57.969 --> 14:58.669\n第三个呢，\n\n14:58.669 --> 15:01.619\n就是说我们看就是中医治疗这些话具有明显的优势，\n\n15:01.619 --> 15:04.270\n可以改善患者射呼吸困量的症状，\n\n15:04.270 --> 15:05.320\n延缓疾病的减。\n\n15:06.463 --> 15:07.088\n研究显示呢，\n\n15:07.088 --> 15:10.213\n冬虫夏草制剂有一定的抗氧、抗氧化、抗。\n\n15:11.322 --> 15:14.747\n定位化的作用可以通过抑制PG贝塔一的表达，\n\n15:14.747 --> 15:17.096\n调整一型和二级细胞，\n\n15:17.096 --> 15:17.646\n抑制平衡，\n\n15:17.646 --> 15:19.971\n达到抗纤维化的作用。\n\n15:20.171 --> 15:21.396\n临床研究显示呢，\n\n15:21.396 --> 15:21.822\n就是。\n\n15:22.640 --> 15:24.840\n能够严重改善肺心患者的这个肺。\n\n15:27.794 --> 15:28.294\n谢谢大家。\n\n","v0347cg10004d62582aljht3c7gfa88g",935,918,"2026-01-25 10:13:04"," 肺纤维化的认识与药物进展 | 最新研究、治疗药物与预防措施  "," 肺纤维化, 特发性肺纤维化, 肺纤维化治疗, 肺纤维化药物, 肺纤维化症状, 肺纤维化研究进展, 抗纤维化药物  "," 本文深入探讨肺纤维化的病因、症状及最新药物进展，涵盖抗纤维化药物的研究突破和临床治疗策略，帮助患者和家属了解疾病管理与前沿治疗方案。","2026-04-14 18:00:00",[38],{"menuId":39,"menuName":40,"parentId":17,"orderNum":41,"path":42,"component":43,"isFrame":44,"isCache":45,"menuType":46,"visible":27,"status":17,"createDept":6,"remark":25,"createTime":47,"children":48,"columnImage":49,"columnLogo":50,"uncheckedLogo":6,"checkedLogo":6,"isHot":17,"isHome":17,"forceLogin":17,"color":6,"seoTitle":51,"seoKeywords":52,"seoDescription":53,"contentNum":6,"promotionalPoster":54,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":55,"routerPath":42,"componentInfo":43},"1986622624134549505","科普视频",3,"video","/video.html","1","0","T","2025-11-07 10:31:58",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:09:40/0d7fcb56-3dc4-4dcb-99ca-a5d5c438378e.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:09:43/958efac7-dd02-4681-b8fd-0dd84b1bbf42.png","健康科普视频大全,了解你的健康生活","健康科普视频, 戒烟视频, 饮食健康视频, 胸痛科普, 用药知识, 职业健康视频, 贫血科普, 眼健康视频","精选健康科普视频,涵盖戒烟、胸痛、饮食、用药与职业健康等多个主题,让你轻松获取科学健康知识,提升生活质量。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:09:45/fa8fe113-deaa-4454-8105-d629769963dd.png","Video","重大疾病",4,"https://vod.haohuanjiao.com/huanjiao/specialistVideo/864270/a86f86a1-a090-4de8-942a-5cde9713ed61.tmp?a=0&auth_key=1789028740-1c70990498f247f1bc01d6aa13096567-0-fa6a207e70e2d69054de5e74900887c1&br=1035&bt=1035&cd=0%7C0%7C0&ch=0&cr=0&cs=0&dr=0&ds=&eid=v0347cg10004d62582aljht3c7gfa88g&er=0&l=20260811061002F4A6A74368100F88D8C3&lr=&mime_type=video_mp4&net=0&pl=0&qs=13&rc=ajtpOjZrbzU4OTczNGY3M0ApO2RqZndtZDs1ZzMzajo2eWc1XmRgcWdeNS9hLS1kNDBzc2Q1YzQwZWkvMjMxLS5gMS06Yw%3D%3D&vl=&vr=",true,{"code":9,"msg":58,"message":6,"data":6,"success":59},{"code":9,"msg":10,"message":6,"data":62,"success":59},{"pageNo":27,"pageSize":63,"result":64,"totalSize":17},10,[],{"code":9,"msg":10,"message":6,"data":66,"success":59},{"authors":67,"appraiseDimensionScoresVos":68},[],[]]